← Browse by Condition
Medical Condition

prevention of pneumonic plague resulting from aerosol exposure to yersenia pestis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07207408 Phase 2
Recruiting

Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

Enrollment
148 pts
Location
United States
Sponsor
Dynavax Technologies Corporati...
View Trial →